Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

Abstract Mesenchymal stem cells (MSCs) have emerged as a highly promising strategy in regenerative medicine due to their self-renewal, pluripotency and immunomodulatory properties. MSCs are nonhematopoietic, multipotent stem cells that can differentiate into various mesodermal lineages and modulate...

Full description

Saved in:
Bibliographic Details
Main Authors: Xia Han, Rongdong Liao, Xiang Li, Cantong Zhang, Shaochuan Huo, Lei Qin, Yi Xiong, Tailin He, Guozhi Xiao, Tianfeng Zhang
Format: Article
Language:English
Published: Nature Publishing Group 2025-08-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-025-02313-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225839888039936
author Xia Han
Rongdong Liao
Xiang Li
Cantong Zhang
Shaochuan Huo
Lei Qin
Yi Xiong
Tailin He
Guozhi Xiao
Tianfeng Zhang
author_facet Xia Han
Rongdong Liao
Xiang Li
Cantong Zhang
Shaochuan Huo
Lei Qin
Yi Xiong
Tailin He
Guozhi Xiao
Tianfeng Zhang
author_sort Xia Han
collection DOAJ
description Abstract Mesenchymal stem cells (MSCs) have emerged as a highly promising strategy in regenerative medicine due to their self-renewal, pluripotency and immunomodulatory properties. MSCs are nonhematopoietic, multipotent stem cells that can differentiate into various mesodermal lineages and modulate the immune system. The therapeutic potential of MSCs from different tissues has been widely explored in preclinical models and clinical trials for human diseases, ranging from autoimmune diseases and inflammatory disorders to neurodegenerative diseases and orthopedic injuries. The therapeutic effects of MSCs can be mediated through the release of bioactive molecules, including growth factors, cytokines, and extracellular vesicles, which play crucial roles in modulating the local cellular environment, promoting tissue repair, angiogenesis, and cell survival, and exerting anti-inflammatory effects. MSCs can also interact with various immune cells, such as T cells, B cells, dendritic cells, and macrophages, modulating the immune response through both direct cell‒cell interactions and the release of immunoregulatory molecules. This review delves into the molecular mechanisms, signaling pathways, and regulatory factors that underpin the therapeutic effects of MSCs. This review also highlights the clinical applications and challenges associated with the use of MSC-based drugs to promote the safety and efficacy of MSC-based therapies. Overall, this comprehensive review provides valuable insights into the current state of MSC research and its potential for transforming the field of regenerative medicine as well as immune-mediated inflammatory diseases.
format Article
id doaj-art-69525ca61d404e45b18b4dccb8dd63bf
institution Kabale University
issn 2059-3635
language English
publishDate 2025-08-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj-art-69525ca61d404e45b18b4dccb8dd63bf2025-08-24T11:54:01ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352025-08-0110114110.1038/s41392-025-02313-9Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studiesXia Han0Rongdong Liao1Xiang Li2Cantong Zhang3Shaochuan Huo4Lei Qin5Yi Xiong6Tailin He7Guozhi Xiao8Tianfeng Zhang9Research Institute, Shenzhen Hospital (Futian) of Guangzhou University of Chinese MedicineDepartment of Orthopedics, Zhujiang Hospital, Southern Medical UniversityGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, College of Pharmacy, Guizhou Medical UniversityDepartment of Rheumatology and Immunology, Shenzhen Third People’s HospitalResearch Institute, Shenzhen Hospital (Futian) of Guangzhou University of Chinese MedicineDepartment of Orthopedics, Shenzhen Nanshan People’s Hospital, and the 6th Affiliated Hospital of Shenzhen University Medical SchoolResearch Institute, Shenzhen Hospital (Futian) of Guangzhou University of Chinese MedicineDepartment of Rheumatology and Immunology, Shenzhen Third People’s HospitalDepartment of Biochemistry, Homeostatic Medicine Institute, School of Medicine, Shenzhen Key Laboratory of Cell Microenvironment, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Southern University of Science and TechnologyResearch Institute, Shenzhen Hospital (Futian) of Guangzhou University of Chinese MedicineAbstract Mesenchymal stem cells (MSCs) have emerged as a highly promising strategy in regenerative medicine due to their self-renewal, pluripotency and immunomodulatory properties. MSCs are nonhematopoietic, multipotent stem cells that can differentiate into various mesodermal lineages and modulate the immune system. The therapeutic potential of MSCs from different tissues has been widely explored in preclinical models and clinical trials for human diseases, ranging from autoimmune diseases and inflammatory disorders to neurodegenerative diseases and orthopedic injuries. The therapeutic effects of MSCs can be mediated through the release of bioactive molecules, including growth factors, cytokines, and extracellular vesicles, which play crucial roles in modulating the local cellular environment, promoting tissue repair, angiogenesis, and cell survival, and exerting anti-inflammatory effects. MSCs can also interact with various immune cells, such as T cells, B cells, dendritic cells, and macrophages, modulating the immune response through both direct cell‒cell interactions and the release of immunoregulatory molecules. This review delves into the molecular mechanisms, signaling pathways, and regulatory factors that underpin the therapeutic effects of MSCs. This review also highlights the clinical applications and challenges associated with the use of MSC-based drugs to promote the safety and efficacy of MSC-based therapies. Overall, this comprehensive review provides valuable insights into the current state of MSC research and its potential for transforming the field of regenerative medicine as well as immune-mediated inflammatory diseases.https://doi.org/10.1038/s41392-025-02313-9
spellingShingle Xia Han
Rongdong Liao
Xiang Li
Cantong Zhang
Shaochuan Huo
Lei Qin
Yi Xiong
Tailin He
Guozhi Xiao
Tianfeng Zhang
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
Signal Transduction and Targeted Therapy
title Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
title_full Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
title_fullStr Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
title_full_unstemmed Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
title_short Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
title_sort mesenchymal stem cells in treating human diseases molecular mechanisms and clinical studies
url https://doi.org/10.1038/s41392-025-02313-9
work_keys_str_mv AT xiahan mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT rongdongliao mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT xiangli mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT cantongzhang mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT shaochuanhuo mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT leiqin mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT yixiong mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT tailinhe mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT guozhixiao mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies
AT tianfengzhang mesenchymalstemcellsintreatinghumandiseasesmolecularmechanismsandclinicalstudies